Helicobacter pylori vaccine - ProvalisAlternative Names: HP0310; Ulsatat
Latest Information Update: 16 May 2007
At a glance
- Originator Provalis
- Developer Provalis; University of Newcastle, Australia
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Helicobacter infections